ATC/DDD Classi�cationATC/DDD Classi�cation (Temp - PDF document

207 207 ATC/DDD Classi�cationATC/DDD Classi�cation (Temporary)The following ATC codes and DDDs were agreed at the meeting of the WHO International Working Group for Drug Statistics Methodology in March 2014.Comments or objections to the decisions from the meeting should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology before 12014. If no objections are received before this date, the new ATC codes and DDDs will be considered �nal and included in the January 2015 version of the ATC/DDD New ATC 5th level codes: ATC levelINN/Common nameATC codelinagliptin and empagli�ozinD11AX22mifepristone, combinationstri�uridine, combinationsL04AC11�uticasone furoateNew DDDs: INN/Common nameATC codeP (depot) Administration Route: O=oral; P=parenteral1) ATC code valid from January 2015 (current code L01XC04). WHO Drug Information Vol. 28, No. 2, 2014 208 ATC/DDD Classi�cation (Final)The following ATC codes, DDDs and alterations were agreed at the meeting of the WHO International Working Group for Drug Statistics Methodology in October 2013. These are considered as �nal and will be included in the January 2015 version of the ATC/DDD Index. The WHO Collaborating Centre for Drug Statistics Methodology can be contacted at whocc@fhi.no. The inclusion of a substance in the lists does not imply any recommendation for use in medicine or pharmacy.New ATC 5th level codes: ATC levelINN/Common nameATC codeatorvastatin and acetylsalicylic acidatorvastatin, acetylsalicylic acid and azilsartan medoxomil and diureticsazithromycin, �uconazole and brinzolamide, combinationscefepime and amikacin cepeginterferon alfa-2bcipro�oxacin and metronidazole cipro�oxacin and ornidazolecipro�oxacin and tinidazole J01RA11coagulation factor Xcyclopentolate, combinationsS01FA54darunavir and cobicistatdonepezil, memantine and Ginkgo elosulfase alfa�orbetaben ( 209 New ACT 5th level codes, continuedATC levelINN/Common nameATC codeformoterol and aclidinium bromide indometacin and antiinfectivesA03FA07lamivudine, abacavir and lamivudine and tenofovir disoproxil lansoprazole, amoxicillin and lansoprazole, clarithromycin and lansoprazole, combinationsmetformin and canagli�ozinmetronidazole, combinationsnebivolol and other hypertensivesnitrofurantoin, combinationsnor�oxacin and tinidazoleo�oxacin and ornidazole palonosetron, combinationspeginterferon beta-1aper�ubutane polymer microspherespipenzolate and psycholepticsrabeprazole, combinationsrisedronic acid and colecalciferolrosuvastatin, amlodipine and rosuvastatin and amlodipinetetracycline and oleandomycin thiocolchicoside, combinationstiotropium bromide, combinations WHO Drug Information Vol. 28, No. 2, 2014ATC/DDD 210 New ACT 5th level codes, continuedATC levelINN/Common nameATC codeG04BE11umeclidinium bromideChange of ATC codes: INN/Common namePrevious ATC New ATCChange of ATC level names: ATC codeacetylsalicylic acid and acetylsalicylic acid, combinations Antihypertensives for pulmonary arterial hypertensioncefuroxime, combinations with other cefuroxime and metronidazole spiramycin, combinations with other spiramycin and metronidazole New DDDs: INN/Common nameATC codeB02BD11cepeginterferon alfa-2bdimethyl fumaratenalmefene Administration Route: O=oral; P=parenteral WHO Drug Information Vol. 28, No. 2, 2014 ATC/DDD Classi�cation (Final)